Prognostic inflammatory-immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter study.

Front Immunol · 2026 · PMC13269074 · PMID 42311666

Europe PMC DOI

hedged sentence

0.3110

closest p · 6.2× alpha

0.3110

boldest claim

The sentences

a nonsignificant trendP = 0.311not close (p > 0.1)

While short-term therapy (<3 years) showed a nonsignificant trend toward improved survival compared with no treatment (P = 0.311), only treatment durations exceeding 3 years resulted in a significantly superior survival outcome (P = 0.004).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.